Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05253235 · ClinicalTrials.gov registry record · NA

Health and Resilience Projects: Foundations

A NA study of Substance Use, sponsored by University of Georgia.

Recruiting
Registry status
NA
Development phase
650
Enrollment target
1
Study location

NCT05253235 is a NA study of Substance Use that is actively recruiting participants, run by University of Georgia. The registered enrollment target is 650 participants, below the 1,253-participant average among 88 other Substance Use trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05253235, a NA study of Substance Use, is actively recruiting participants, sponsored by University of Georgia.

RECRUITING
Registry status
NA
Development phase
650 participants
Enrollment target
1
Study location

Study Summary

The Health and Resilience Project (HARP): Foundations is investigating the efficacy of the Strong African American Families (SAAF) intervention in promoting the health and well being of African American adolescents. Youth age 10-13 and their primary caregivers are randomly assigned to receive SAAF or to a control group. Participants complete baseline and follow-up measures regarding vulnerability to substance use based on a neuroimmune model of stress coping.

Conditions Studied

Interventions

  • BEHAVIORAL SAAF
  • OTHER Receipt of parenting book

Study Locations (1)

Georgia

  • Center for Family Research - Athens

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 2022-01-25
Est. Completion 2027-12-31
Phase NA

Sponsor

University of Georgia

59 total trials

What the Registry Record Tells You About NCT05253235

The ClinicalTrials.gov registry entry for NCT05253235 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,253-participant average among 88 other Substance Use trials with a reported enrollment target (48% lower). The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which SAAF is the first listed.

NCT05253235 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05253235 about?

NCT05253235 is a clinical study titled "Health and Resilience Projects: Foundations". The Health and Resilience Project (HARP): Foundations is investigating the efficacy of the Strong African American Families (SAAF) intervention in promoting the health and well being of African American adolescents. Youth age 10-13 and their primary caregivers are randomly assigned to receive SAAF o...

What is the current status of trial NCT05253235?

This trial is currently recruiting. It is a NA study. The enrollment target is 650 participants. The study started on 2022-01-25. Estimated completion is 2027-12-31.

What conditions does trial NCT05253235 study?

This clinical trial studies the following conditions: Substance Use.

What interventions are being tested in trial NCT05253235?

The interventions under investigation include: SAAF (BEHAVIORAL), Receipt of parenting book (OTHER).

Who is sponsoring clinical trial NCT05253235?

This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05253235 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.